A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors
Clinical trial NCT00500903 · COMPLETED
Trial details
- NCT number
- NCT00500903
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-15
- Primary completion
- 2010-08-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.